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There was less post-PCI bleeding, fewer major cardiac adverse events, shorter length of stay, and lower hospital costs for the transradial (TR) interventional approach compared to the transfemoral (TF) route. 1 The adoption of TR route as the first approach in patients undergoing PCI is supported by data from several institutions including our own.
2 Two large randomized trials "Radial Versus Femoral Access for Coronary Angiography and Intervention in patients with acute coronary syndromes" 3 and "Minimizing Adverse hemorrhagic event by Transradial access and systemic Implementation of AngioX program" 4 have clearly demonstrated the advantages of radial access compared to the femoral approach in a reduction of major adverse cardiac events and major bleeding. This approach has been also extensively investigated in high-risk setting of patients, such as the elderly patients or women. A recent meta-analysis of 777 841 elderly patients concluded that the TR approach is associated with a reduced risk of stroke, lower rate of vascular complications overall, and mortality benefit in fragile patients with a higher rate of crossover but acceptably low. 5 Conversely, still unclear is the role of TR approach in women, who seem to be more prone to adverse events, often underreported in clinical studies. 6 The main complication related to TR procedures in this setting is due to the smaller diameter of the radial artery, compared to males, and a major rate of vasospasm, 7 the most common cause of radial procedure failure. 8 The Study of Access Site for Enhancement for PCI for women trial 9 demonstrated that the TR approach in women undergoing PCI did not significantly reduce bleeding or vascular complications and access site crossover was observed more often in patients assigned to radial access than the TF. Moreover, a substudy comparing the quality of life or functional status measured after radial versus femoral approach for cardiac catheterization did not observe any difference according to site access. 10 Despite this finding, patient preference for the same access strategy for repeat procedures was significantly greater among patients assigned to the TR compared to the TF approach.
More promising results come from The Matrix Access Trial, the largest randomized trial that compared radial and femoral access in acute coronary syndrome. This study clearly demonstrated that the radial approach reduced net clinical events through a reduction in major bleeding and all-cause mortality. 11 In the subgroup analysis, the results of the trial were also confirmed in female patients with a 28% reduction of risk of allcause mortality, myocardial infarction, stroke, or Bleeding Academic Research Consortium 3 or 5 bleeding (odds ratio: 0.72; confidence interval: 0.56-0.93; P ¼ .012).
11 Interestingly, the data in favor of TR access in women were even better compared to the male subgroup (0.89; 0.76-1.05; P ¼ .16).
The economic aspects should not to be underestimated. The study by Jin et al showed an important reduction in costs and length of hospital stay. 1 Another study demonstrated that the TR approach was associated with a cost saving exceeding US$800/patient compared to the TF approach. 12 However, the present study is the first that investigated the costs and length of hospital stay in women patients showing a significant reduction when the TR access was used. 1 Finally, in agreement with the big trials, 3, 4 this study confirmed the better profile of the TR approach compared to the TF route and suggested that radial access should become the default access for female patients undergoing PCI.
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.
